rs371394378
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_031206.7(LAS1L):āc.1892G>Cā(p.Gly631Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000488 in 1,208,726 control chromosomes in the GnomAD database, including 1 homozygotes. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_031206.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAS1L | NM_031206.7 | c.1892G>C | p.Gly631Ala | missense_variant | 12/14 | ENST00000374811.8 | NP_112483.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAS1L | ENST00000374811.8 | c.1892G>C | p.Gly631Ala | missense_variant | 12/14 | 1 | NM_031206.7 | ENSP00000363944.3 |
Frequencies
GnomAD3 genomes AF: 0.0000355 AC: 4AN: 112632Hom.: 0 Cov.: 24 AF XY: 0.0000287 AC XY: 1AN XY: 34786
GnomAD3 exomes AF: 0.0000170 AC: 3AN: 176921Hom.: 0 AF XY: 0.0000317 AC XY: 2AN XY: 63025
GnomAD4 exome AF: 0.0000502 AC: 55AN: 1096094Hom.: 1 Cov.: 31 AF XY: 0.0000415 AC XY: 15AN XY: 361832
GnomAD4 genome AF: 0.0000355 AC: 4AN: 112632Hom.: 0 Cov.: 24 AF XY: 0.0000287 AC XY: 1AN XY: 34786
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.1892G>C (p.G631A) alteration is located in exon 12 (coding exon 12) of the LAS1L gene. This alteration results from a G to C substitution at nucleotide position 1892, causing the glycine (G) at amino acid position 631 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Wilson-Turner syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 20, 2022 | This variant is present in population databases (rs371394378, gnomAD 0.005%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The alanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 464823). This variant has not been reported in the literature in individuals affected with LAS1L-related conditions. This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 631 of the LAS1L protein (p.Gly631Ala). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at